Carlos Manuel
Rodríguez Ortigosa
Investigador hasta 2021
![Foto de Carlos Manuel](/img/nophoto.png)
![Foto de Clínica Universitaria de Navarra](/img/noimage_org.png)
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (10)
2019
-
Splicing events in the control of genome integrity: Role of SLU7 and truncated SRSF3 proteins
Nucleic Acids Research, Vol. 47, Núm. 7, pp. 3450-3466
-
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis
Hepatology, Vol. 69, Núm. 4, pp. 1632-1647
2013
2010
-
Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2-/- Mice
PLoS ONE, Vol. 5, Núm. 12
-
Reply
Hepatology
2006
-
Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger
Hepatology, Vol. 43, Núm. 2, pp. 266-275
1997
-
Enhanced urinary excretion of cGMP in liver cirrhosis: Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion
Digestive Diseases and Sciences, Vol. 42, Núm. 7, pp. 1416-1420
-
S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: A study with isolated and perfused rat liver
Hepatology, Vol. 26, Núm. 2, pp. 330-335
1992
-
Role of leukotrienes B4 and C4 in liver allograft rejection.
Transplant international : official journal of the European Society for Organ Transplantation, Vol. 5 Suppl 1
1991
-
Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide
Journal of Hepatology, Vol. 12, Núm. 2, pp. 170-175